Novo rival Eli Lilly wins approval for weight-loss pill in China
Verified: 2 outlets in 2 countries have reported this story since Nov 12.
The American pharmaceutical company Eli Lilly has been given the green light to sell its weight loss pill, orforglipron, in China. The news agency Reuters reports Thursday. The company is Danish Novo’s biggest competitor in the market for diabetes and weight loss drugs. The two rivals have long fought to reach the patients who have…
How sure are we
Two or more outlets reported this story and its reliability score reached 65%, so WorldPulse marks it verified. That means more than one outlet says so, not that it is proven true.
Who reported it
- Nov 12, 11:56 AM UTCFirst reportEli Lilly breaks ground with China approval for obesity pillbdnews24.com ↗
- Nov 12, 3:44 PM UTC+4 h· you’re reading thisNovo rival Eli Lilly wins approval for weight-loss pill in Chinacphpost.dk ↗
- Verified: a second independent outlet reported itNov 12, 3:44 PM UTC · +4 h
[Claude] Both reports cover Eli Lilly's China approval of its orforglipron weight-loss pill, and nothing in them conflicts.
1h agoScore bands
What moves the score
Not in the score: AI checks and reader flags. Verified is separate: two or more independent outlets and a score of at least 65%.
Very high · How we score this